Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Danielle, Castillo"'
Autor:
Yanin Chavarri-Guerra, Cynthia Villarreal-Garza, Ana S Ferrigno, Alejandro Mohar, Dione Aguilar, Rosa M Alvarez-Gomez, Lenny Gallardo-Alvarado, Azucena del Toro-Valero, Gregorio Quintero-Beulo, Francisco Gutierrez-Delgado, José Luis Rodriguez-Olivares, Maria Fernanda Ochoa-Chavez, Gubidxa Gutierrez-Seymour, Danielle Castillo, Josef Herzog, Jeffrey N Weitzel
Publikováno v:
Salud Pública de México, Vol 64, Iss 1, Pp 41-48 (2022)
Objective. Describe the prevalence of breast cancer (BC)- associated germline pathogenic variants (PVs) among Mexican patients with triple-negative BC (TNBC). Materials and methods. The spectrum of PVs identified among patients with TNBC who were enr
Externí odkaz:
https://doaj.org/article/92d21866689548dfa42a2745b1bfde85
Autor:
Kathleen R. Blazer, Yanin Chavarri-Guerra, Cynthia Villarreal Garza, Bita Nehoray, Alejandro Mohar, Adrian Daneri-Navarro, Azucena del Toro, Dione Aguilar, Jazmin Arteaga, Rosa Maria Álvarez, Rosa Mejia, Josef Herzog, Danielle Castillo, Maria Fernandez, Jeffrey N. Weitzel
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 992-1002 (2021)
PURPOSEGenomic cancer risk assessment (GCRA) is standard-of-care practice that uses genomic tools to identify individuals with increased cancer risk, enabling screening for early detection and cancer prevention interventions. GCRA is not available in
Externí odkaz:
https://doaj.org/article/3f0f224e84bb42d0873b58186acde2c2
Autor:
Josef S. Herzog, Yanin Chavarri-Guerra, Danielle Castillo, Julio Abugattas, Cynthia Villarreal-Garza, Sharon Sand, Jessica Clague-Dehart, Rosa M. Alvarez-Gómez, Talia Wegman-Ostrosky, Alejandro Mohar, Pamela Mora, Azucena Del Toro-Valero, Adrian Daneri-Navarro, Yenni Rodriguez, Marcia Cruz-Correa, Patricia Ashton-Prolla, Bárbara Alemar, Rosa Mejia, Lenny Gallardo, Robin Shaw, Kai Yang, Aleck Cervantes, Kevin Tsang, Bita Nehoray, Hugo Barrera Saldana, Susan Neuhausen, Jeffrey N. Weitzel
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract The prevalence and contribution of BRCA1/2 (BRCA) pathogenic variants (PVs) to the cancer burden in Latin America are not well understood. This study aims to address this disparity. BRCA analyses were performed on prospectively enrolled Lati
Externí odkaz:
https://doaj.org/article/cf08a7f700d74cf8b958e3c34a9237a2
Autor:
Yanin Chávarri-Guerra, María T Bourlon, José Luis Rodríguez-Olivares, Luis Orozco, Deborah Bazua, Andrés Rodríguez-Faure, Mirza Jacqueline Alcalde-Castro, Elena Castro, Danielle Castillo, Josef Herzog, Jeffrey Weitzel
Publikováno v:
Clinical Genitourinary Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3bad5d1ad544e6848bb78950d1530bb
https://doi.org/10.1016/j.clgc.2023.05.012
https://doi.org/10.1016/j.clgc.2023.05.012
Autor:
Gad Rennert, Bita Nehoray, Flavio Lejbkowicz, Sara Dishon, Shiri Kalet, Joseph Herzog, Thomas Slavin, Danielle Castillo, Kevin Tsang, Sharon Sand, Hedy S Rennert, Jeffrey Weitzel
Publikováno v:
Cancer Research. 82:P3-13
Background: After decades of research on Ashkenazi Jewish (AJ) founder mutations in BRCA1 and BRCA2 (BRCA), there is still little known about genetics in non-AJ and Arab breast cancer populations in Israel and non-BRCA pathogenic variants (PV) in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58da94989f1cbd307192d716cc4545af
https://doi.org/10.1158/1538-7445.sabcs21-p3-13-07
https://doi.org/10.1158/1538-7445.sabcs21-p3-13-07
Autor:
Cynthia Villarreal-Garza, Ana S. Ferrigno, Alejandro Aranda-Gutierrez, Paul H. Frankel, Nora H. Ruel, Alan Fonseca, Steven Narod, Yanin Chavarri-Guerra, Erika Sifuentes, Maria Cristina Magallanes-Hoyos, Josef Herzog, Danielle Castillo, Rosa M. Alvarez-Gomez, Alejandro Mohar-Betancourt, Jeffrey N. Weitzel
Publikováno v:
Cancer Res Commun
The presence of BRCA pathogenic variants (PV) in triple-negative breast cancer (TNBC) is associated with a distinctive genomic profile that makes the tumor particularly susceptible to DNA-damaging treatments. However, patients with BRCA PVs can devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec46982cb1f0ec494ea9ffb678c073d8
https://doi.org/10.1158/2767-9764.crc-21-0099
https://doi.org/10.1158/2767-9764.crc-21-0099
Autor:
Danielle Castillo, Dione Aguilar, Yanin Chavarri-Guerra, Kathleen R. Blazer, Rosa María Alvarez, Adrian Daneri-Navarro, Alejandro Mohar, Maria E. Fernandez, Cynthia Villarreal Garza, Azucena Del Toro, Josef Herzog, Jazmin Arteaga, Bita Nehoray, Jeffrey N. Weitzel, Rosa Mejia
Publikováno v:
JCO Global Oncology
PURPOSE Genomic cancer risk assessment (GCRA) is standard-of-care practice that uses genomic tools to identify individuals with increased cancer risk, enabling screening for early detection and cancer prevention interventions. GCRA is not available i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59114512e222acab89627dd5d9c91df2
https://doi.org/10.1200/go.20.00587
https://doi.org/10.1200/go.20.00587
Autor:
Sophie Hyman, Jeffrey N. Weitzel, Huma Q. Rana, Samantha Stokes, Judy Garber, Danielle Castillo, Alison Schwartz, Nadine Tung
Publikováno v:
JCO Precision Oncology. :1677-1686
PURPOSE Multigene panel testing (MGPT) identifies TP53 pathogenic or likely pathogenic (P/LP) variants in patients with diverse phenotypes, of which only one is classic Li-Fraumeni syndrome. Low variant allelic fraction (VAF) in TP53 found on germlin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44dad8a176fa76e76bf5da830655b2e8
https://doi.org/10.1200/po.21.00278
https://doi.org/10.1200/po.21.00278
Autor:
Jeffrey N. Weitzel, Patricia Ashton-Prolla, Sharon Sand, Kai Yang, Danielle Castillo, Hugo Alberto Barrera Saldaña, Cynthia Villarreal-Garza, Adrian Daneri-Navarro, Marcia Cruz-Correa, Rosa Mejia, Rosa María Álvarez-Gómez, Alejandro Mohar, Pamela Mora, Lenny Gallardo, Aleck Cervantes, Kevin Karwing Tsang, Josef Herzog, Bita Nehoray, Robin J. Shaw, Yenni Rodriguez, Azucena Del Toro-Valero, Yanin Chavarri-Guerra, Bárbara Alemar, Jessica Clague-Dehart, Susan L. Neuhausen, Julio Abugattas, Talia Wegman-Ostrosky
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
NPJ Breast Cancer
NPJ Breast Cancer
The prevalence and contribution of BRCA1/2 (BRCA) pathogenic variants (PVs) to the cancer burden in Latin America are not well understood. This study aims to address this disparity. BRCA analyses were performed on prospectively enrolled Latin America
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e3ae76bf6c4341952cbc8f92e482b22
https://doaj.org/article/cf08a7f700d74cf8b958e3c34a9237a2
https://doaj.org/article/cf08a7f700d74cf8b958e3c34a9237a2
Autor:
Sharon Sand, Rosa Mejia, Karen L. Reckamp, Terrence C. Tsou, Stacy W. Gray, Catherine A. Marcum, Thomas P. Slavin, Amie J. Hass, Marianna Koczywas, Donna Stearns, Jeffrey N. Weitzel, Mary M. Vecchio, Kirsten M. Babski, Mihaela C. Cristea, Yenni P. Rodriguez, Aleck Cervantes, Carolyn E. Behrendt, Pamela Mora, Ravi Salgia, Danielle Castillo
Publikováno v:
Cancer
Background To identify additional at-risk groups for lung cancer screening, which targets persons with a long history of smoking and thereby misses younger or nonsmoking cases, the authors evaluated germline pathogenic variants (PVs) in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a352f47588124058efc0d4ff7ed7842
https://doi.org/10.1002/cncr.33573
https://doi.org/10.1002/cncr.33573